Juvenile myoclonic epilepsy (JME) is one of the most common age-related idiopathic generalized epilepsies and includes about 5%-10% of all kinds of epilepsy (1). It presents as a combination of myoclonic jerks (in all cases), generalized tonic-clonic seizures (GTCS) (in more than 80-97% of the cases), absence seizures (2) and its inheritance is a complicated process. Epileptic seizures typi-cally commence during adolescence and puberty (12-18 years) (1).